Anne S. de Groot
Chief Executive Officer at EpiVax, Inc.
Profile
Anne S.
de Groot is the founder of EpiVax, Inc. (founded in 1998) and GAIA Vaccine Foundation (founded in 2002).
She currently holds positions as the Director at Epivax Oncology, Inc., Professor at Brown University, and Professor at the University of Rhode Island (since 2013).
Dr. de Groot completed her undergraduate degree at Smith College in 1978 and obtained her doctorate degree from The University of Chicago in 1983.
Anne S. de Groot active positions
| Companies | Position | Start |
|---|---|---|
EpiVax, Inc.
 EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Chief Executive Officer | 1997-12-31 |
| Brown University | Corporate Officer/Principal | - |
| University of Rhode Island | Corporate Officer/Principal | - |
| GAIA Vaccine Foundation | Founder | 2001-12-31 |
Epivax Oncology, Inc.
 Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Director/Board Member | - |
Training of Anne S. de Groot
| Smith College | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
EpiVax, Inc.
EpiVax, Inc. Pharmaceuticals: OtherHealth Technology EpiVax, Inc. provides reengineering therapeutic proteins and design new vaccines. Its services include immunogenicity screening, immunogenicity testing, protein engineering and vaccine design and redesign. The company was founded by Anne S. De Groot in 1998 and is headquartered in Providence, RI. | Health Technology |
| GAIA Vaccine Foundation | |
Epivax Oncology, Inc.
Epivax Oncology, Inc. BiotechnologyHealth Technology Epivax Oncology, Inc. engages in computational-immunology, genomics and vaccine design. It develops mutanome-directed, neo-epitope personalized therapeutic vaccines. The company was founded by Gad Berdugo, Anne De Groot, and Martin William in 2017 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Anne S. de Groot
